SEQUOIA Arm D: Zanubrutinib in CLL/SLL with del(17p)

 SLIDE KIT   12/2021

Zanubrutinib in combination with venetoclax for patients with treatment-naive chronic lymphocytic leukemia or small lymphocytic lymphoma with del(17p): early results from arm of the SEQUOIA (BGB-3111-304) trial

Rating

Rate this resource